{"name": "Pepscan Therapeutics",
 "permalink": "pepscan-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/pepscan-therapeutics",
 "homepage_url": "http://www.pepscantherapeutics.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@pepscan.com",
 "phone_number": "31-320-225300",
 "description": "",
 "created_at": "Sat Apr 24 03:35:06 UTC 2010",
 "updated_at": "Wed Jan 05 14:08:24 UTC 2011",
 "overview": "\u003Cp\u003EPEPSCAN Therapeutics is a world leader in applying peptide \u0026amp; protein mimicry technology for the generation of molecular therapeutics, in particular monoclonal antibodies and therapeutic peptides.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[136,
       98],
      "assets/images/resized/0008/4786/84786v1-max-150x150.jpg"],
     [[136,
       98],
      "assets/images/resized/0008/4786/84786v1-max-250x250.jpg"],
     [[136,
       98],
      "assets/images/resized/0008/4786/84786v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u20ac12M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.accessmylibrary.com/coms2/summary_0286-17649896_ITM",
    "source_description": "Pepscan Secures Euro 7 Million in its Second Financing Round and Launches its Phase I/II GNRH Vaccine Trial for the Treatment of Hormone Dependant Prostate Cancer.",
    "raised_amount": 7000000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2006,
    "funded_month": 9,
    "funded_day": 19,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Lupus Ventures",
         "permalink": "lupus-ventures",
         "image": null},
       "person": null},
      {"company":
        {"name": "Biox Biosciences",
         "permalink": "biox-biosciences",
         "image": null},
       "financial_org": null,
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "PPM Oost",
         "permalink": "ppm-oost",
         "image":
          {"available_sizes":
            [[[150,
               99],
              "assets/images/resized/0006/1821/61821v2-max-150x150.png"],
             [[188,
               125],
              "assets/images/resized/0006/1821/61821v2-max-250x250.png"],
             [[188,
               125],
              "assets/images/resized/0006/1821/61821v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Technofund Flevoland",
         "permalink": "technofund-flevoland",
         "image": null},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://www.thefreelibrary.com/Pepscan+Secures+Euro+5+Million+in+First+Financing+Round.-a0133856834",
    "source_description": "Pepscan Secures Euro 5 Million in First Financing Round.",
    "raised_amount": 5000000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2005,
    "funded_month": 7,
    "funded_day": 8,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "PPM Oost",
         "permalink": "ppm-oost",
         "image":
          {"available_sizes":
            [[[150,
               99],
              "assets/images/resized/0006/1821/61821v2-max-150x150.png"],
             [[188,
               125],
              "assets/images/resized/0006/1821/61821v2-max-250x250.png"],
             [[188,
               125],
              "assets/images/resized/0006/1821/61821v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Lupus Ventures",
         "permalink": "lupus-ventures",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Wageningen Business Generator",
         "permalink": "wageningen-business-generator",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Technofund Flevoland",
         "permalink": "technofund-flevoland",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Zuidersluisweg 2",
    "address2": "8243 RC Lelystad",
    "zip_code": "",
    "city": "",
    "state_code": null,
    "country_code": "NLD",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Mercator Therapeutics Inc. has entered into a research and licensing collaboration with Pepscan Therapeutics",
    "stoned_year": 2011,
    "stoned_month": 1,
    "stoned_day": 3,
    "source_url": "http://www.masshightech.com/stories/2011/01/03/daily10-Mercator-Pepscan-partner-on-cancer-therapy-developments.html",
    "source_text": null,
    "source_description": "Mercator, Pepscan partner on cancer therapy developments",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Pepscan Therapeutics",
      "permalink": "pepscan-therapeutics"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        118],
       "assets/images/resized/0008/4787/84787v1-max-150x150.jpg"],
      [[250,
        197],
       "assets/images/resized/0008/4787/84787v1-max-250x250.jpg"],
      [[450,
        355],
       "assets/images/resized/0008/4787/84787v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}